Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a simple ICU care checklist cut delirium and boost Long-Term recovery?

NCT ID NCT07783035

Knowledge-focused Sponsor: Hospital H+ Queretaro Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 24, 2026 · Last updated Aug 25, 2026 · Updated 1 time

Summary

This study looks at whether intensive care units (ICUs) in Latin America that follow a standard care bundle more closely—covering sedation checks, breathing trials, delirium monitoring, early mobility, and family involvement—see lower rates of delirium and better long-term outcomes. Researchers will track 580 adult ICU patients, checking daily for delirium and mobility, and follow up by phone at 3 and 6 months to assess thinking, mood, and quality of life. No experimental treatment is given; the goal is to see if better adherence to this care approach is linked to improved patient outcomes.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
ABCDEF bundle compliance assessment (observational, no experimental intervention)
What this could lead to
If higher compliance with the ABCDEF bundle is linked to less delirium and better recovery, it could support wider adoption of this care approach in ICUs.
What could go wrong
This is an observational study, so it can show associations but not prove cause and effect. Results may be influenced by differences in ICU practices and patient populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 580 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Aug 2026

An estimate. Start dates often move.

Expected to finish

Nov 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Adult critically ill patients admitted to six multipurpose intensive care units across four Latin American countries (Colombia, Mexico, Chile, and Argentina) with an expected ICU stay of at least 48 hours

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age ≥18 years Admission to the ICU during the 3-month recruitment period * Expected ICU length of stay ≥48 hours * Written informed consent provided by the patient or legal representative (or eligibility for deferred consent according to local regulations) Exclusion Criteria: * History of moderate to severe dementia * Severe chronic brain disease (e.g., previous disabling stroke, Parkinson's disease, advanced multiple sclerosis) * Severe prior intellectual disability or prior functional cognitive dependence * Palliative sedation scheduled from ICU admission * Deep irreversible coma or diagnosed brain death * Uncorrected bilateral deafness * Non-Spanish speakers * Refusal or explicit request by the family not to participate

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Critical illness are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Critical Illness delirium postintensive care syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Critical illness Icu delirium Post intensive care syndrome

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.